Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Daniel Jose Pineiro
This session was co-chaired by Prof. Stephan Felix (Greifswald, DE) and Prof. Daniel José Piñeiro (Buenos Aires, AR)
The aim of the session was to give an update of inflammatory, peripartum and Chagasic cardiomyopathies and endomyocardial fibrosis.It was the first time that it was held a joint session between the European Society of Cardiology and the Interamerican society of Cardiology during an ESC Congress.
Heinz-Peter SCHULTHEISS (Berlin, DE) gave an excellent overview of inflammatory cardiomyopathies and currents therapies. He emphasized that diagnosis and treatment of inflammatory cardiomyopathies requires assessment of viral infection and immunologic causes.
Karen SLIWA-HAHNLE (Cape Town, ZA) presented hints on diagnosis and management of peripartum cardiomyopathy. She highlighted the importance of treatment with inhibitors of prolactin (bromocriptine).
Antonio RIBEIRO (Belo Horizonte, BR) gave a well-balanced talk on Chagasic cardiomyopathy. It is caused by the infection of parasite Trypanosoma cruzi transmited by an insect (triatoma infestans) in South America, but is extended to many countries due to emigration of people. Twenty-five percent of the patients infected develop cardiac involvement, characterized by abnormalities of the conduction system, arrhythmias, left ventricular aneurism, heart failure and thromboembolism.
Ricardo MIGLIORE (San Martin, AR) reported on endomyocardial fibrosis. This cardiomyopathy has two forms: Loeffler´s endocarditis and Davies´s disease which probably represent the spectrum of the same pathologic process. Fibrothrombosis of the apex and subvalvular regions are common as well as diastolic dysfunction with progression to global heart failure.
Cardiomyopathies in Europe and Americas